Pharmacokinetic‐pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite α‐hydroxymidazolam in healthy volunteers
暂无分享,去创建一个
Meindert Danhof | Bert Tuk | M. Danhof | D. Breimer | A. Cohen | Jaap W Mandona | B. Tuk | A. L. Steveninck | Douwe D Breimer | Jaap W Mandona | Alfred L Steveninck | Adam F Cohen | A. Steveninck
[1] M. Danhof,et al. Quantification of the EEG Effect of Midazolam by Aperiodic Analysis in Volunteers , 1990, Clinical pharmacokinetics.
[2] H. Schoemaker,et al. A comparison of the sensitivities of adaptive tracking, eye movement analysis, and visual analog lines to the effects of incremental doses of temazepam in healthy volunteers , 1991, Clinical pharmacology and therapeutics.
[3] L B Sheiner,et al. Semiparametric approach to pharmacokinetic-pharmacodynamic data. , 1989, The American journal of physiology.
[4] D. Hommer,et al. Benzodiazepine sensitivity in normal human subjects. , 1986, Archives of general psychiatry.
[5] M. Eckert,et al. Comparison of the effects of intravenously administered midazolam, triazolam and their hydroxy metabolites. , 1983, British journal of clinical pharmacology.
[6] A. T. Smith,et al. Rate of entrance of benzodiazepines into the brain determined by eye movement recording. , 1983, British journal of clinical pharmacology.
[7] D. Greenblatt,et al. Concentration‐independent plasma protein binding of benzodiazepines , 1983, The Journal of pharmacy and pharmacology.
[8] M Danhof,et al. Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration‐EEG effect relationship , 1992, British journal of pharmacology.
[9] M Danhof,et al. Pharmacokinetic‐pharmacodynamic modeling of midazolam effects on the human central nervous system , 1988, Clinical pharmacology and therapeutics.
[10] P. Heizmann,et al. Relationship between plasma concentration and effect of midazolam after oral and intravenous administration. , 1983, British journal of clinical pharmacology.
[11] H. Akaike. A new look at the statistical model identification , 1974 .
[12] M. Sunzel. Determination of midazolam and the alpha-hydroxy metabolite by gas chromatography in small plasma volumes. , 1989, Journal of chromatography.
[13] P. Kroboth,et al. Pharmacokinetics of the Newer Benzodiazepines , 1989, Clinical pharmacokinetics.
[14] D. Greenblatt,et al. Effect of Age, Gender, and Obesity on Midazolam Kinetics , 1984, Anesthesiology.
[15] Willy Haefely,et al. Recent advances in the molecular pharmacology of Benzodiazepine receptors and in the structure-activity relationships of their agonists and antagonists , 1985 .
[16] P. Hartvig,et al. Relation of sedation and amnesia to plasma concentrations of midazolam in surgical patients , 1988, Clinical pharmacology and therapeutics.
[17] L F Dell'Osso,et al. Saccadic velocity characteristics: intrinsic variability and fatigue. , 1979, Aviation, space, and environmental medicine.
[18] U Klotz,et al. Midazolam kinetics , 1981, Clinical pharmacology and therapeutics.
[19] B L Ehrenberg,et al. Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo , 1989, Clinical pharmacology and therapy.
[20] P Heizmann,et al. Pharmacokinetics and bioavailability of midazolam in man. , 1983, British journal of clinical pharmacology.
[21] S. Garattini,et al. Formation of active metabolites of psychotropic drugs. An updated review of their significance. , 1990, Clinical pharmacokinetics.
[22] M. Gibaldi,et al. Noncompartmental Analysis Based on Statistical Moment Theory , 1982 .
[23] M. Danhof,et al. Pharmacokinetic‐pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration , 1991, British journal of pharmacology.
[24] Lawrence Stark,et al. Overlapping saccades and glissades are produced by fatigue in the saccadic eye movement system , 1975, Experimental Neurology.